Immunovant Inc (IMVT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Operating Expenses | 438,152 | 282,709 | 218,276 | 156,033 | 108,117 |
| Operating Income | -438,152 | -282,709 | -218,276 | -156,033 | -108,117 |
| Other Income | 25,203 | 23,940 | 7,325 | -781 | 328 |
| Pre-tax Income | -412,949 | -258,769 | -210,951 | -156,814 | -107,789 |
| Income Tax | 891 | 567 | 9 | -84 | -358 |
| Net Income Continuous | -413,840 | -259,336 | -210,960 | -156,730 | -107,431 |
| Net Income | $-413,840 | $-259,336 | $-210,960 | $-156,730 | $-107,431 |
| EPS Basic Total Ops | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 |
| EPS Basic Continuous Ops | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 |
| EPS Diluted Total Ops | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 |
| EPS Diluted Continuous Ops | -2.73 | -1.88 | -1.71 | -1.43 | -1.22 |
| EPS Diluted Before Non-Recurring Items | -2.73 | -1.78 | -1.71 | -1.43 | -1.22 |
| EBITDA(a) | $-437,775 | $-282,478 | $-218,083 | $-155,907 | $-108,052 |